13 February 2017 - Deborah Wilkes
Archived
GlaxoSmithKline has launched Flonase Sensimist Allergy Relief in the US, as it reported a 2% rise in worldwide sales at its Consumer Healthcare business in the fourth quarter of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.